Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
907
NCT00880347
Blood Gene Expression Signature in Patients Diagnosed With Probable Alzheimer's Disease Compared to Patients Suffering From Other Types of Dementia
Phase: N/A
Role: Lead Sponsor
Start: Feb 29, 2008
Completion: Feb 28, 2011
NCT00880412
A Study to Determine the Clinical Safety/Tolerability and Exploratory Efficacy of EHT 0202 as Adjunctive Therapy to Acetylcholinesterase Inhibitor in Mild to Moderate Alzheimer's Disease
Phase: Phase 2
Start: Apr 30, 2008
Completion: Aug 31, 2009
NCT01465360
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Start: Nov 30, 2011
Completion: Not specified